Discovery and characterisation of recifin
Recifin 的发现和表征
基本信息
- 批准号:10487083
- 负责人:
- 金额:$ 21.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AxinellaBinding SitesBiochemicalBiological AssayCamptothecinComplexCysteineEnzyme KineticsFractionationLengthLibrariesMass Spectrum AnalysisMolecular TargetNamesNatural ProductsPatternPeptide Sequence DeterminationPeptidesPoriferaSourceStructureStructure-Activity RelationshipTopoisomerase Inhibitorsaqueousbeta pleated sheetcancer cellchemical synthesisdisulfide bondhigh throughput screeningimprovedinhibitor/antagonistnovelpharmacophoretyrosyl-DNA phosphodiesterase
项目摘要
Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a molecular target for the sensitization of cancer cells to the topoisomerase inhibitor camptothecin and its derivatives. High-throughput screening of natural product extract libraries for inhibitors of TDP1 activity resulted in the discovery of a bioactive aqueous extract of the marine sponge, Axinella sp. Bioassay-guided fractionation of the source extract resulted in the isolation of the active component which was determined to be a novel, 42-residue cysteine-rich peptide we named recifin. The primary sequence and disulfide bonding pattern of recifin was determined using a combination of Edman degradation and tandem mass spectroscopy de novo protein sequencing. The NMR structure revealed a novel fold comprising a four strand anti-parallel beta-sheet and two helical turns stabilized by a complex disulfide bond network that creates an embedded ring around one of the strands. Recifin inhibited full-length TDP1 but not N-terminally truncated TDP1 in biochemical assays. Enzyme kinetics studies revealed that recifin can specifically modulate the enzymatic activity of full-length TDP1 while not affecting a truncated form of TDP1, suggesting an allosteric binding site for recifin on TDP1.
酪氨酸-DNA磷酸二酯酶1(TDP 1)是肿瘤细胞对拓扑异构酶抑制剂喜树碱及其衍生物敏感的分子靶点。高通量筛选天然产物提取物库的TDP 1活性抑制剂,导致发现了一种生物活性的水提取物的海绵,Axinella sp.生物测定引导分馏的源提取物导致分离的活性成分,这被确定为一种新的,42个残基的富含半胱氨酸的肽,我们命名为recifin。recifin的一级序列和二硫键模式,确定使用Edman降解和串联质谱从头蛋白质测序的组合。NMR结构揭示了一种新的折叠,包括一个四链反平行β-折叠和两个由复杂的二硫键网络稳定的螺旋转角,该网络在其中一条链周围产生嵌入的环。Recifin抑制全长TDP 1,但不N-末端截短的TDP 1在生化测定。酶动力学研究表明,recifin可以特异性地调节全长TDP 1的酶活性,而不影响TDP 1的截短形式,这表明recifin在TDP 1上的变构结合位点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ingrid Schroeder其他文献
Ingrid Schroeder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ingrid Schroeder', 18)}}的其他基金
Discovery and development of voltage-gated sodium channel inhibitors
电压门控钠通道抑制剂的发现和开发
- 批准号:
10487119 - 财政年份:
- 资助金额:
$ 21.32万 - 项目类别:
Discovery of bioactive peptides targeting ion channels upregulated in cancer
发现针对癌症中上调离子通道的生物活性肽
- 批准号:
10702807 - 财政年份:
- 资助金额:
$ 21.32万 - 项目类别:
Synthesis and Development of Trefoil Factor Peptides
三叶因子肽的合成与开发
- 批准号:
10262601 - 财政年份:
- 资助金额:
$ 21.32万 - 项目类别:
Discovery and development of voltage-gated sodium channel inhibitors
电压门控钠通道抑制剂的发现和开发
- 批准号:
10262606 - 财政年份:
- 资助金额:
$ 21.32万 - 项目类别:
Synthesis and Development of Trefoil Factor Peptides
三叶因子肽的合成与开发
- 批准号:
10487114 - 财政年份:
- 资助金额:
$ 21.32万 - 项目类别:
Discovery and development of voltage-gated sodium channel inhibitors
电压门控钠通道抑制剂的发现和开发
- 批准号:
10702806 - 财政年份:
- 资助金额:
$ 21.32万 - 项目类别:
相似海外基金
BIOCHEMICAL CHARACTERIZATION OF OPIOID BINDING SITES
阿片类药物结合位点的生化特征
- 批准号:
3207446 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIOID BINDING SITES
阿片类药物结合位点的生化特征
- 批准号:
2116613 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIATE BINDING SITES
阿片结合位点的生化特征
- 批准号:
3207448 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIATE BINDING SITES
阿片结合位点的生化特征
- 批准号:
3207451 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIOID BINDING SITES
阿片类药物结合位点的生化特征
- 批准号:
6515354 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIOID BINDING SITES
阿片类药物结合位点的生化特征
- 批准号:
6730581 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
Biochemical Characterization of Opioid BInding Sites
阿片类药物结合位点的生化特征
- 批准号:
8422976 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIOID BINDING SITES
阿片类药物结合位点的生化特征
- 批准号:
6634154 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIATE BINDING SITES
阿片结合位点的生化特征
- 批准号:
3207444 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF OPIATE BINDING SITES
阿片结合位点的生化特征
- 批准号:
3207450 - 财政年份:1980
- 资助金额:
$ 21.32万 - 项目类别: